tiprankstipranks
Arrowhead Pharmaceuticals (GB:0HI3)
LSE:0HI3

Arrowhead Pharmaceuticals (0HI3) Stock News & Sentiment

0 Followers
Athira Pharma appoints Javier San Martin as Chief Medical Officer
PremiumThe Fly
Athira Pharma appoints Javier San Martin as Chief Medical Officer
9d ago
Arrowhead announces new Phase 2 SHASTA-2 study of plozasiran in SHTG
PremiumThe Fly
Arrowhead announces new Phase 2 SHASTA-2 study of plozasiran in SHTG
17d ago
Arrowhead begins EAP to avail plozasiran outside of trials for patients with FCS
PremiumThe Fly
Arrowhead begins EAP to avail plozasiran outside of trials for patients with FCS
1M ago
Arrowhead CFO Myszkowski sells 40,000 common shares
PremiumThe Fly
Arrowhead CFO Myszkowski sells 40,000 common shares
2M ago
Arrowhead doses first patients in ARO-DM1 trial
PremiumThe Fly
Arrowhead doses first patients in ARO-DM1 trial
2M ago
Arrowhead rumor mentioned in Betaville blog
PremiumThe Fly
Arrowhead rumor mentioned in Betaville blog
2M ago
Arrowhead Pharmaceuticals Appoints Dr. Hongbo Lu to Board
PremiumCompany Announcements
Arrowhead Pharmaceuticals Appoints Dr. Hongbo Lu to Board
2M ago
More ARWR News >

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:0HI3’s Media Buzz Sentiment?
Currently, no data Available
What is GB:0HI3’s weekly average amount of articles?
Currently, no data Available
What is GB:0HI3’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
IMVTImmunovant
INSPInspire Medical Systems
EVOEvotec AG
ISRGIntuitive Surgical
ABTAbbott Labs
Showing the stocks with the most bullish news sentiment over the past week
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis